Domestic market for erectile dysfunction drugs contested by three foreign-invested firms

Published: 2003-08-21 06:59:00

Updated: 2003-08-21 06:59:00

Following the recent approval of Bayer's Levitra tablet, a new drug for the treatment of erectile dysfunction, the domestic market for erectile dysfunction drugs has emerged as an arena of tripartite competition among three multinational firms: Pfizer's Viagra, Lilly's Cialis and Bayer's Levitra....

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK